A prospective cohort study to define infectious burden, the seroprevalence of vaccine preventable pathogens and immune recovery in the first year following completion of therapy in patients with acute lymphoblastic leukemia (ALL)

Complete Title: A prospective cohort study to define infectious burden, the seroprevalence of vaccine preventable pathogens and immune recovery in the first year following completion of therapy in patients with acute lymphoblastic leukemia (ALL)
Trial Phase: N/A
Investigator: Eric Chow

Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.
Checklist icon

Join a Clinical Trial

Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each clinical trial.

Contact Us

If you are seeking to schedule an appointment, we are here to help. You can either call us or fill out our online appointment request form.

N/A
Eric Chow
RG1123480
A prospective cohort study to define infectious burden, the seroprevalence of vaccine preventable pathogens and immune recovery in the first year following completion of therapy in patients with acute lymphoblastic leukemia (ALL)